{"cluster": 48, "subcluster": 24, "abstract_summ": "Conclusion: COVID-19 patients combined with CVD are associated with a higher risk of mortality.Results COVID-19 patients with CVD showed: (1) more severe pathological changes in the lung, (2) elevated injury-related enzymes including \u03b1-hydroxybutyrate dehydrogenase (HDBH), lactate dehydrogenase (LDH), \u03b3-glutamyltransferase (GGT), creatine kinase (CK) and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR) and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD.Methods 83 confirmed COVID-19 patients were divided into the CVD (n=42) and non-CVD (n=41) group according to their medical history.BACKGROUND To investigate the effect of cardiovascular disease (CVD) on the global pandemic, coronavirus disease 2019 (COVID-19), we analyzed the cases of laboratory-confirmed COVID-19 patients in Wuhan.Conclusion: Elevated RDW in hospitalized COVID-19 patients is associated with a significantly increased risk of mortality and septic shock.", "title_summ": "Metabolic indicators associated with non-communicable diseases deteriorated in COVID-19 outbreak: evidence from a two-center, retrospective studyElevated RDW is Associated with Increased Mortality Risk in COVID-19Red blood cell distribution width (RDW) in Hospitalized COVID-19 PatientsCardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19A Novel Indicator Predicts 2019 Novel Coronavirus Infection in Subjects with Diabetes[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ?", "title_abstract_phrases": "Conclusion: COVID-19 patients combined with CVD are associated with a higher risk of mortality.Methods 83 confirmed COVID-19 patients were divided into the CVD (n=42) and non-CVD (n=41) group according to their medical history.Results COVID-19 patients with CVD showed: (1) more severe pathological changes in the lung, (2) elevated injury-related enzymes including \u03b1-hydroxybutyrate dehydrogenase (HDBH), lactate dehydrogenase (LDH), \u03b3-glutamyltransferase (GGT), creatine kinase (CK) and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR) and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD.Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).BACKGROUND To investigate the effect of cardiovascular disease (CVD) on the global pandemic, coronavirus disease 2019 (COVID-19), we analyzed the cases of laboratory-confirmed COVID-19 patients in Wuhan.Conclusion: Elevated RDW in hospitalized COVID-19 patients is associated with a significantly increased risk of mortality and septic shock."}